Skip to main content

XEOMIN (Merz Australia Pty Ltd)

Product name
XEOMIN
Date registered
Evaluation commenced
Decision date
Approval time
180 working days (255)
Active ingredients
incobotulinum toxin A
Registration type
EOI
Indication

XEOMIN is now also indicated for the treatment of:

  • Spasticity of upper limb
  • Upper facial lines
    • Lateral periorbital lines (crow's feet)
    • Horizontal forehead lines

Help us improve the Therapeutic Goods Administration site